I
321.36
0.36 (0.11%)
前收盘价格 | 321.00 |
收盘价格 | 319.00 |
成交量 | 615,511 |
平均成交量 (3个月) | 911,733 |
市值 | 22,615,674,880 |
市盈率 (P/E TTM) | 57.80 |
预期市盈率 (P/E Forward) | 75.76 |
价格/销量 (P/S) | 10.42 |
股市价格/股市净资产 (P/B) | 16.39 |
52周波幅 | |
利润日期 | 6 Aug 2025 - 11 Aug 2025 |
营业毛利率 | 18.29% |
营业利益率 (TTM) | 15.61% |
稀释每股收益 (EPS TTM) | 5.55 |
季度收入增长率 (YOY) | 28.80% |
季度盈利增长率 (YOY) | -31.30% |
总债务/股东权益 (D/E MRQ) | 131.40% |
流动比率 (MRQ) | 4.47 |
营业现金流 (OCF TTM) | 406.50 M |
杠杆自由现金流 (LFCF TTM) | 84.25 M |
资产报酬率 (ROA TTM) | 6.94% |
股东权益报酬率 (ROE TTM) | 37.92% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (US) | 看跌 | 看跌 |
Medical Devices (全球的) | 看跌 | 看跌 | |
股票 | Insulet Corporation | 看涨 | 看涨 |
AIStockmoo 评分
0.4
分析师共识 | 1.5 |
内部交易活动 | NA |
价格波动 | -0.5 |
技术平均移动指标 | 2.5 |
技术振荡指标 | -2.0 |
平均 | 0.38 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Mid Growth |
内部持股比例 | 0.29% |
机构持股比例 | 102.73% |
52周波幅 | ||
目标价格波幅 | ||
高 | 380.00 (Citigroup, 18.25%) | 购买 |
380.00 (Goldman Sachs, 18.25%) | 购买 | |
中 | 360.00 (12.02%) | |
低 | 266.00 (Barclays, -17.23%) | 保留 |
平均值 | 346.43 (7.80%) | |
总计 | 6 购买, 1 保留 | |
平均价格@调整类型 | 308.10 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Truist Securities | 16 Jun 2025 | 365.00 (13.58%) | 购买 | 306.59 |
Goldman Sachs | 30 May 2025 | 380.00 (18.25%) | 购买 | 325.03 |
Raymond James | 27 May 2025 | 360.00 (12.02%) | 购买 | 326.64 |
Citigroup | 22 May 2025 | 380.00 (18.25%) | 购买 | 321.00 |
Wolfe Research | 13 May 2025 | 350.00 (8.91%) | 购买 | 314.46 |
Oppenheimer | 09 May 2025 | 324.00 (0.82%) | 购买 | 310.67 |
Barclays | 30 Apr 2025 | 266.00 (-17.23%) | 保留 | 252.29 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合